A Proteomic Platform Enables to Test for AML Normalization In Vitro
Meier-Menches, Samuel M., Neuditschko, Benjamin
, Janker, Lukas , Gerner, Marlene C., Schmetterer, Klaus G., Reichle, Albrecht and Gerner, Christopher
(2022)
A Proteomic Platform Enables to Test for AML Normalization In Vitro.
Frontiers in Chemistry 10.
Date of publication of this fulltext: 29 Feb 2024 12:56
Article
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Frontiers in Chemistry | ||||
| Publisher: | Frontiers | ||||
|---|---|---|---|---|---|
| Place of Publication: | LAUSANNE | ||||
| Volume: | 10 | ||||
| Date | 2022 | ||||
| Institutions | Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie) | ||||
| Identification Number |
| ||||
| Keywords | TRANS-RETINOIC ACID; ACUTE PROMYELOCYTIC LEUKEMIA; ACUTE MYELOID-LEUKEMIA; ARSENIC TRIOXIDE; DIFFERENTIATION THERAPY; CELLS; MECHANISMS; TARGET; ACTIVATION; EXPRESSION; AML-acute myeloid leukaemia; arsenic trioxide; cancer; differentiation; normalization; plecstatin-1; proteomics; Ruthenium | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 57519 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric